Bruce C Cozadd is Chairman & CEO of Jazz Pharmaceuticals plc. Currently has a direct ownership of 429,809 shares of JAZZ, which is worth approximately $45.9 Million. The most recent transaction as insider was on Mar 05, 2024, when has been sold 22,436 shares (Ordinary Shares) at a price of $117.53 per share, resulting in proceeds of $2,636,903. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 430K
0% 3M change
10.89% 12M change
Total Value Held $45.9 Million

BRUCE C COZADD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2024
SELL
Payment of exercise price or tax liability
$2,636,903 $117.53 p/Share
22,436 Reduced 4.96%
429,809 Ordinary Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
50,187 Added 9.99%
452,245 Ordinary Shares
Jan 17 2024
SELL
Payment of exercise price or tax liability
$1,458,746 $119.13 p/Share
12,245 Reduced 2.96%
402,058 Ordinary Shares
Jan 17 2024
BUY
Grant, award, or other acquisition
-
26,545 Added 6.02%
414,303 Ordinary Shares
Mar 05 2023
SELL
Payment of exercise price or tax liability
$3,124,311 $142.78 p/Share
21,882 Reduced 5.34%
387,584 Ordinary Shares
Mar 03 2023
BUY
Grant, award, or other acquisition
-
42,388 Added 9.38%
409,466 Ordinary Shares
Feb 01 2023
SELL
Open market or private sale
$155,790 $155.79 p/Share
1,000 Reduced 0.27%
367,078 Ordinary Shares
Jan 03 2023
SELL
Open market or private sale
$479,370 $159.79 p/Share
3,000 Reduced 0.81%
368,078 Ordinary Shares
Dec 01 2022
SELL
Open market or private sale
$157,000 $157.0 p/Share
1,000 Reduced 0.27%
371,078 Ordinary Shares
Nov 10 2022
SELL
Open market or private sale
$300,000 $150.0 p/Share
2,000 Reduced 0.53%
372,028 Ordinary Shares
Oct 03 2022
SELL
Open market or private sale
$6,099,975 $135.0 p/Share
45,185 Reduced 10.78%
374,028 Ordinary Shares
Oct 03 2022
BUY
Exercise of conversion of derivative security
$3,719,573 $59.13 p/Share
62,905 Added 13.05%
419,213 Ordinary Shares
Sep 06 2022
SELL
Open market or private sale
$1,186,493 $154.03 p/Share
7,703 Reduced 2.12%
356,308 Ordinary Shares
Sep 06 2022
BUY
Exercise of conversion of derivative security
$573,561 $59.13 p/Share
9,700 Added 2.6%
363,011 Ordinary Shares
Aug 01 2022
SELL
Open market or private sale
$1,128,370 $154.55 p/Share
7,301 Reduced 2.02%
354,311 Ordinary Shares
Aug 01 2022
BUY
Exercise of conversion of derivative security
$513,906 $52.98 p/Share
9,700 Added 2.61%
361,612 Ordinary Shares
Jul 05 2022
SELL
Open market or private sale
$1,383,642 $157.68 p/Share
8,775 Reduced 2.43%
351,912 Ordinary Shares
Jul 05 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.62%
360,687 Ordinary Shares
Jun 02 2022
SELL
Open market or private sale
$150,000 $150.0 p/Share
1,000 Reduced 0.28%
350,987 Ordinary Shares
Jun 01 2022
SELL
Open market or private sale
$939,158 $147.62 p/Share
6,362 Reduced 1.78%
351,987 Ordinary Shares
Jun 01 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.64%
358,349 Ordinary Shares
May 02 2022
SELL
Open market or private sale
$1,140,764 $157.13 p/Share
7,260 Reduced 2.04%
348,502 Ordinary Shares
May 02 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.65%
355,762 Ordinary Shares
Apr 04 2022
SELL
Open market or private sale
$1,703,807 $158.17 p/Share
10,772 Reduced 3.02%
346,062 Ordinary Shares
Apr 04 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.65%
356,834 Ordinary Shares

Also insider at

SLRN
ACELYRIN, Inc.
BCC

Bruce C Cozadd

Chairman & CEO
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ